Top Story

Blood test could lead to earlier detection of gastrointestinal cancers

January 24, 2020
FDA News

FDA approves Tazverik for advanced epithelioid sarcoma

January 24, 2020
The FDA granted accelerated approval to tazemetostat for patients aged 16 years or older with metastatic or locally advanced epithelioid sarcoma ineligible for complete…
In the Journals

Ruxolitinib shows efficacy for certain patients with chronic neutrophilic leukemia, atypical CML

January 24, 2020
Ruxolitinib induced responses in about one-third of a cohort of patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia, according to results…
Advanced Practice

CAR T-cell therapy for children: Meeting patient and family needs

HemOnc Today, January 25, 2020
Amy Barry, MSN, RN, PPCNP-BC; Colleen Callahan, MSN, RN, CRNP; Diane Baniewicz, MSN, RN, CRNP
Chimeric antigen receptor T-cell therapy is a promising immunotherapy for children with refractory or relapsed acute lymphoblastic leukemia who otherwise have limited…

Genetic anticipation and mentorship

HemOnc Today, January 25, 2020
Derek Raghavan, MD, PhD
It has been exactly 40 years since Richard M. Fox, MB, PhD, FRACP; Tatiana Jelihovsky, MBBS, DCP, FRCPA, FRCPath; and I published our paper on genetic anticipation in…
More Headlines »

Picking a PI in MM: Asking & Answering the W5

Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Takeda Oncology.

More »
Meeting News

VIDEO: Serum protein changes indicate response to siltuximab in Castleman disease

December 16, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress


Ace the Case: A 60-Year-Old Female With a Thyroid Nodule

There is no commercial support for this activity.

More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next